Paolo Pozzilli

Professor Paolo Pozzilli is a leading academic at Queen Mary University of London, holding a Professor of Clinical Research (Diabetes) position at the Centre of Immunobiology, Blizard Institute, Faculty of Medicine and Dentistry. He is also a Professor of Endocrinology and Diabetes at Campus Bio-Medico University of Rome (UCBM). His research focuses on type 1 diabetes (T1D) and latent autoimmune diabetes in adults (LADA), including pathogenesis, biomarker discovery, and clinical trials for beta-cell preservation and immunomodulation.

• Editor-in-Chief of Diabetes Metabolism Research & Reviews
• Coordinator of EU-funded Action LADA project
• International PhD programme in Integrated Biomedical Sciences and Bioethics (UCBM-QMUL)

Research Highlights:

• First identification of oxPTM-INS-Ab as novel T1D biomarkers
• Investigations into immunomodulatory drugs for T1D treatment
• Stem cell differentiation into insulin-producing cells
• Analysis of bone fracture risk in T1D patients

Scientific Awards:

• Andrew Cudworth Memorial Award
• Morgagni Award for Best Young Investigator
• Marie Kugel Award
• Joseph Hoet Memorial Lecture (2016)
• Multiple prizes from diabetes societies